The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
BMC Cancer
(Jul 2023)
Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo
Yu-Yin Xu,
Li Chen,
Gui-Lan Wang,
Jia-Ming Zhou,
Yi-Xin Zhang,
Yin-Ze Wei,
Yuan-Yuan Zhu,
Jing Qin
Affiliations
Yu-Yin Xu
Department of Pathological Anatomy, Nantong University
Li Chen
Department of Pathological Anatomy, Nantong University
Gui-Lan Wang
Department of Pathological Anatomy, Nantong University
Jia-Ming Zhou
Department of Pathological Anatomy, Nantong University
Yi-Xin Zhang
Department of Pathology, Affiliated Tumor Hospital, Nantong University
Yin-Ze Wei
Department of Pathology, Affiliated Tumor Hospital, Nantong University
Yuan-Yuan Zhu
Biomics (Nantong) Co., Ltd
Jing Qin
Department of Pathological Anatomy, Nantong University
DOI
https://doi.org/10.1186/s12885-023-11135-3
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 1
Abstract
Read online
No abstracts available.
WeChat QR code
Close